ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 984,93
-0,99%
Dow Jones
37 927,80
-1,19%
DAX
17 932,17
-1,10%
Brent Oil
85,995
-1,48%
Bitcoin
60 107,04
-5,88%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Canadá
  5. TSX
  6. Aptose Biosciences Inc (APS)

  7. Aptose Biosciences Inc (APS) Actualités

APS

Aptose Biosciences (APS)

Aptose Biosciences Inc
De:
Trier par:
 Showing the most relevant articles for your search:TSX:APS
DateHeureSourceTitreSymboleSociété
27/04/202017h02PR Newswire (Canada)L'OCRCVM permet la reprise de la négociation - APSTSX:APSAptose Biosciences Inc
27/04/202017h00PR Newswire (Canada)Suspension de la négociation par l'OCRCVM - APSTSX:APSAptose Biosciences Inc
27/04/202016h59PR Newswire (Canada)IIROC Trade Resumption - APSTSX:APSAptose Biosciences Inc
27/04/202016h58PR Newswire (Canada)IIROC Trading Halt - APSTSX:APSAptose Biosciences Inc
10/06/201523h00PR Newswire (US)Aptose Biosciences announces results of annual and special meeting of shareholdersTSX:APSAptose Biosciences Inc
02/06/201520h00PR Newswire (US)Aptose Biosciences Granted Orphan Drug Designation by the U.S. FDA for APTO-253 in Acute Myeloid LeukemiaTSX:APSAptose Biosciences Inc
05/05/201522h15PR Newswire (US)Aptose Biosciences Reports Results for the First Quarter Ended March 31, 2015TSX:APSAptose Biosciences Inc
30/04/201514h00PR Newswire (US)Aptose Biosciences To Host First Quarter Ended March 31, 2015 Financial Results Conference Call and WebcastTSX:APSAptose Biosciences Inc
23/03/201513h30PR Newswire (US)Aptose Biosciences Announces Appointment of Dr. Michael Andreeff to Scientific Advisory BoardTSX:APSAptose Biosciences Inc
23/03/201513h00PR Newswire (US)Aptose Biosciences to Present at the 12th Annual BIO Asia International ConferenceTSX:APSAptose Biosciences Inc
05/03/201514h00PR Newswire (Canada)Aptose Biosciences to Present at the 27th Annual ROTH ConferenceTSX:APSAptose Biosciences Inc
03/03/201522h30PR Newswire (US)Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014TSX:APSAptose Biosciences Inc
26/02/201514h00PR Newswire (US)Aptose Biosciences To Host Quarter and Seven Month Transition Period Ended December 31, 2014 Conference Call and WebcastTSX:APSAptose Biosciences Inc
25/02/201522h39PR Newswire (US)Aptose Biosciences to Present at the Cowen & Company 35th Annual Healthcare ConferenceTSX:APSAptose Biosciences Inc
19/02/201514h00PR Newswire (Canada)Aptose Biosciences to Present at the RBC Capital Markets 2015 Global Healthcare ConferenceTSX:APSAptose Biosciences Inc
20/01/201523h02PR Newswire (US)Aptose Biosciences Appoints Dr. Bradley Thompson to the Audit CommitteeTSX:APSAptose Biosciences Inc
14/01/201500h45PR Newswire (US)Aptose Biosciences Doses First Patient in Phase 1b Clinical Study of APTO-253 in Relapsed or Refractory Hematological Maligna...TSX:APSAptose Biosciences Inc
12/01/201514h00PR Newswire (Canada)Aptose Biosciences to Present at Biotech Showcase™ 2015TSX:APSAptose Biosciences Inc
15/12/201414h00PR Newswire (Canada)Aptose Biosciences Announces Appointment of Dr. Erich Platzer to Board of DirectorsTSX:APSAptose Biosciences Inc
09/12/201414h00PR Newswire (US)Aptose Biosciences Presents APTO-253 Preclinical Data at 56th American Society of Hematology Annual MeetingTSX:APSAptose Biosciences Inc
05/12/201414h00PR Newswire (US)Aptose Biosciences to Present at Oppenheimer & Co. 25th Annual Healthcare ConferenceTSX:APSAptose Biosciences Inc
03/12/201414h00PR Newswire (US)Aptose Biosciences to Present Preclinical Research Update for APTO-253 at the 56th American Society of Hematology Annual Meet...TSX:APSAptose Biosciences Inc
17/11/201414h00PR Newswire (US)Aptose Biosciences to Present at The Stifel 2014 Healthcare ConferenceTSX:APSAptose Biosciences Inc
04/11/201422h00PR Newswire (US)Aptose Biosciences reports results for the four months ended September 30, 2014TSX:APSAptose Biosciences Inc
30/10/201412h01PR Newswire (US)Aptose Biosciences To Host Conference Call and Webcast For Four Month Interim Period Ended September 30, 2014TSX:APSAptose Biosciences Inc
21/10/201414h00PR Newswire (US)Aptose Biosciences Announces Approval for Listing on the NASDAQ Capital Market Shares to Begin Trading Under the Symbol APTOTSX:APSAptose Biosciences Inc
03/10/201413h00PR Newswire (US)Aptose Biosciences to Present at the 2014 BIO Investor ForumTSX:APSAptose Biosciences Inc
01/10/201423h16PR Newswire (US)Aptose Biosciences Announces Reverse Stock SplitTSX:APSAptose Biosciences Inc
29/09/201414h30PR Newswire (US)Aptose Biosciences Joins The Leukemia & Lymphoma Society's Groundbreaking Beat AML Research Initiative with Oregon Health & S...TSX:APSAptose Biosciences Inc
25/09/201415h48PR Newswire (US)Aptose Biosciences to Present at Upcoming Investor ConferencesTSX:APSAptose Biosciences Inc
 Showing the most relevant articles for your search:TSX:APS

Dernières Valeurs Consultées

EU
RI
Pernod Ricard
EU
DG
Vinci
NASDAQ
MSFT
Microsoft
EU
ACA
Credit Agricole
NYSE
JPM
JP Morgan Chase
EU
LR
Legrand
EU
CAP
Capgemini
EU
MC
Lvmh Moet Hennessy Louis...
EU
EN
Bouygues
FTSE
UKX
FTSE 100
COIN
ETHUSD
Ethereum
EU
GLE
Societe Generale
NASDAQ
AMZN
Amazon.com
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés